Topical Timolol for Periocular Hemangioma: Report of Further Study

Archives of Ophthalmology
doi 10.1001/archophthalmol.2011.24
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Neuropsychiatric Adverse Events From Topical Ophthalmic Timolol

Clinical Medicine and Research
MedicineHome CareCommunity
2019English

936 Systemic Absorption and Safety of Topical Timolol for Chronic Wounds

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Pharmaceutical Evaluation of the Hospital Grade Preparation of Timolol Gel for Infantile Hemangioma

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
2017English

Periocular Changes in Topical Bimatoprost and Latanoprost Use

Turkish Journal of Medical Sciences
Medicine
2015English

Failed Treatment of Classic Kaposi’s Sarcoma With Topical Timolol: Case Report and Review of the Literature

Cureus
2019English

Peyronie's Disease Following Long-Term Use of Topical Timolol

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2005English

A Study of the Effects of Topical Timolol 0.5% and Bimatoprost 0.03% on the Ocular Surface

Journal of Evidence Based Medicine and Healthcare
2017English

Topical Delivery System of Ophthalmic Drugs by Periocular Injection With Viscous Solution.

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
1999English

Hemangioma Capilar Periocular en 2018: Curso Natural, Indicaciones Para El Tratamiento Y Opciones Terapéuticas

Revista Mexicana de Oftalmologia
Ophthalmology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy